|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 12 3827-3837, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
AM Castle, JE Schwarzbauer, RL Wright and JD Castle
Department of Cell Biology, University of Virginia Health Sciences Center, Charlottesville 22908, USA. amc3c@virginia.edu
In pituitary-derived AtT-20 cells, recombinant fibronectin containing the N-terminal matrix assembly domain and the C-terminal half of fibronectin does not follow the regulated secretory pathway but instead concentrates in distinct organelles prior to secretion. These organelles are larger than the dense-core granules and localize to the cell body at sites that differ from lysosomes, endosomes and endoplasmic reticulum. Unlike the dense-core granules, their discharge is not stimulated by 8-bromo-cyclic-AMP or phorbol esters. The kinetics of intracellular transport and secretion of the recombinant fibronectin suggest that it is present in a post-Golgi pool that turns over more slowly than constitutive vesicles. Indeed, the fibronectin-containing organelles disappear with a half-time of 3 hours after inhibiting protein synthesis. Presence of the organelles correlates with intracellular aggregation of dimeric fibronectin polypeptides. The organelles are absent in cells expressing monomeric recombinant fibronectin (lacking C-terminal dimerization sites) or the C-terminal half of fibronectin (which dimerizes but lacks the N-terminal matrix assembly domain), both of which aggregate less efficiently than dimeric fibronectin. Instead, the latter polypeptides enter the dense-core granules. Thus while the formation of the fibronectin-containing organelles may require efficient aggregation, it may not require a specific structural signal. Moreover, efficient aggregation is not necessarily a prerequisite for following the regulated pathway.
This article has been cited by other articles:
|
|
 |
|
  S. Salemi, S. Yousefi, K. Baltensperger, I. C A F Robinson, A. Eble, D. Simon, P. Czernichow, G. Binder, E. Sonnet, and P. E Mullis Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretion Eur. J. Endocrinol., December 1, 2005; 153(6): 791 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, D.-N. Gu, N. Burton-Wurster, and J. N. MacLeod Absence of the I-10 Protein Segment Mediates Restricted Dimerization of the Cartilage-specific Fibronectin Isoform J. Biol. Chem., May 24, 2002; 277(22): 20095 - 20103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kuliawat, D. Prabakaran, and P. Arvan Proinsulin Endoproteolysis Confers Enhanced Targeting of Processed Insulin to the Regulated Secretory Pathway Mol. Biol. Cell, June 1, 2000; 11(6): 1959 - 1972. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Oyarce and B. A. Eipper Cell Type-specific Storage of Dopamine beta -Monooxygenase J. Biol. Chem., February 4, 2000; 275(5): 3270 - 3278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Dannies Protein Hormone Storage in Secretory Granules: Mechanisms for Concentration and Sorting Endocr. Rev., February 1, 1999; 20(1): 3 - 21. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Castle and A. Castle Intracellular Transport and Secretion of Salivary Proteins Critical Reviews in Oral Biology & Medicine, January 1, 1998; 9(1): 4 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Stahl, R. Wright, J. Castle, and A. Castle The unique proline-rich domain of parotid proline-rich proteins functions in secretory sorting J. Cell Sci., January 6, 1996; 109(6): 1637 - 1645. [Abstract] [PDF]
|
|
|
|
|
|
R. Mouchantaf, U. Kumar, T. Sulea, and Y. C. Patel A Conserved alpha -Helix at the Amino Terminus of Prosomatostatin Serves as a Sorting Signal for the Regulated Secretory Pathway J. Biol. Chem., July 6, 2001; 276(28): 26308 - 26316. [Abstract] [Full Text] [PDF]
|
|
